Market Place
Sourcing Support
Hikma And Amarin`s Generic Drug Case Goes To Supreme Court
28 Apr 2026 //
ENDPOINTS
SFDA Approves OneSource`s Generic Semaglutide in Saudi Arabia
11 Feb 2026 //
EXPRESSPHARMA
Hikma launches TYZAVAN (vancomycin injection, USP) in the US
09 Dec 2025 //
PR NEWSWIRE
Girard Sharp and Motley Rice Announce Proposed Settlement
27 May 2025 //
PR NEWSWIRE
Hikma Pharma to pay $50 million in narcolepsy drug antitrust case
08 May 2025 //
REUTERS
Hikma acquires Novugen`s FDA-approved ANDA for trametinib
17 Apr 2025 //
PR NEWSWIRE
Jazz Pharma to pay $145 M to settle narcolepsy drug antitrust case
09 Apr 2025 //
REUTERS
Hikma gets Health Canada approval for Kloxxado Nasal Spray 8 mg
20 Mar 2025 //
GLOBENEWSWIRE
Teva launches generic version of Novo Nordisk`s diabetes drug Victoza
25 Jun 2024 //
REUTERS
Collegium Authorized Generic Deal with Hikma for Nucynta®
29 Apr 2024 //
GLOBENEWSWIRE
Hikma Sees Signs Of A Bounceback For Generics
02 May 2023 //
PHARMAINTELIGENCE
Hikma accuses Amarin of suppressing generic versions of heart pill
22 Feb 2023 //
REUTERS
Hikma Pharma launches Xyrem’s generic in US
04 Jan 2023 //
EXPRESS PHARMA
Hikma introduces generic Xyremin US market
03 Jan 2023 //
PHARMABIZ
Hikma launches generic Advair Diskus® following FDA approval
17 Dec 2020 //
PRNEWSWIRE
Hikma receives favourable court ruling for its generic Vascepa®
03 Sep 2020 //
PRNEWSWIRE
Hikma confirms favourable ruling in generic Vascepa® patent suit
31 Mar 2020 //
PR NEWSWIRE
Civica Rx & Hikma announce shipments of Heparin & 7 other injectable medicines
10 Dec 2019 //
PRESS RELEASE
Solicitor General Recommends That Supreme Court Deny Certiorari Hikma v. Vanda
09 Dec 2019 //
PATENTDOCS
That generic Advair you`ve been expecting for months? It`ll come, Mylan says
07 Nov 2018 //
FIERCE PHARMA
U.S. appeals court invalidates Acorda patents on MS drug
11 Sep 2018 //
CNBC
Hikma Pharmaceuticals Appoints Kristy Ronco Generics EVP
17 Aug 2018 //
BUSINESSWIRE
New Hikma CEO Olafsson gets to work on 200 more generics layoffs
17 Mar 2018 //
FIERCE PHARMA
FDA sends Hikma back to the clinic with generic Advair
14 Mar 2018 //
FIERCE PHARMA
UPDATE 2-Drugmaker Hikma sees more layoffs in generics business
14 Mar 2018 //
REUTERS
GSK escapes Advair hit for now as second generic bid fails
13 Mar 2018 //
REUTERS
GSK wins new reprieve as Hikma`s generic Advair delayed again
12 Mar 2018 //
REUTERS
Hikma/Vectura’s generic Advair delayed in the US
12 Mar 2018 //
PHARMA TIMES
Former Teva generics chief Olafsson steps in as new Hikma CEO
21 Feb 2018 //
FIERCE PHARMA
Mitigare® (Colchicine): West-Ward Pharma Corp v. Granules Pharmaceuticals, Usa
12 Jan 2018 //
PATENT LITIGATION
Hikma in dispute with FDA over generic Advair,cuts generics sales forecast again
09 Nov 2017 //
REUTERS
Hikma, Vectura in dispute with FDA over generic Advair
08 Nov 2017 //
REUTERS
Hikma jacks up a handful of drug prices as much as 430%
21 Aug 2017 //
FIERCE PHARMA
Setback for Vectura/Hikma’s Advair Diskus generic
12 May 2017 //
PHARMA TIMES
Hikma and Vectura to Develop and License Generic Salmeterol for US Market
23 Nov 2016 //
EUROPEAN PHARMACEUTICAL
Hikma`s ANDA for generic Advair Diskus accepted for filing by FDA
10 Apr 2016 //
CPHI ONLINE
Hikma to buy Boehringer`s U.S. generics unit for $2.65 billion
29 Jul 2015 //
REUTERS
Boehringer charges ahead with sale of U.S. generics biz with bids from Hikma, Mallinckrodt
30 Jun 2015 //
FIERCE PHARMA
Otsuka scrambles to persuade judge to block Abilify copycats
17 Apr 2015 //
FIERCE PHARMA
